4-Methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one has been researched along with 2-methyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, BK; Audia, JE; Bellon, S; Beresini, MH; Cantone, N; Chen, Z; Cochran, AG; Conery, AR; Côté, A; Crawford, TD; Cummings, RT; Dakin, LA; de Leon Boenig, G; Flynn, EM; Hewitt, MC; Huang, OW; Jayaram, H; Kaufman, S; Keller, PJ; Kiefer, JR; Lai, T; Leblanc, Y; Li, Y; Liao, J; Liu, W; Lu, H; Magnuson, S; Murray, J; Nasveschuk, CG; Pardo, E; Pastor, R; Romero, FA; Setser, J; Sims, RJ; Taylor, AM; Tsui, V; Wang, J; Wang, Y; Xu, Z; Yan, F; Yu, D; Zawadzke, L; Zhu, X | 1 |
1 other study(ies) available for 4-Methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one and 2-methyl-2,3,4,5-tetrahydro-1,5-benzoxazepin-4-one
| Article | Year |
|---|---|
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).
Topics: | 2016 |